Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, today announced that Co-Founder and Chief Scientific Officer, Dr. Victor ...

Oral presentation on tau silencing gene therapy VY1706, which has previously shown up to 73% knockdown of tau mRNA in NHPs in ...

VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a ...

Researchers examine how salutogenesis, the active production of health through immune resilience, resists disease.

Ovarian cancer is a cancer in the ovary that is located on both sides of the uterus to produce follicles and make female ...

Aug. 7, 2024 — Bioengineers have developed a noninvasive tool to measure gene expression and gene therapy delivery in specific brain regions using ... New Gene Therapy Approach Shows Promise for ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic code. The company is using this to develop therapies for rare diseases and ...

Acoustic stimulation affects cell development and gene activity, revealing potential applications in biotechnology and ...